Breaking News

Eisai Completes New Injection/Research Building in Japan

EMITS will be Eisai's global base for formulation and modality research.

Author Image

By: Charlie Sternberg

Associate Editor

As part of its strategic investment towards the realization of its medium-term business plan “EWAY Future & Beyond,” Eisai Co., Ltd. has completed construction of the new injection/research building “Eisai Medicine Innovation Technology Solutions” (EMITS) at the Kawashima Industrial Park located in Gifu Prefecture, Japan.   EMITS will be Eisai’s global base for formulation and modality research. In recent years, Eisai’s drug discovery targets have expand...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters